Intas Pharmaceuticals Articles
AstraZeneca in two more Seroquel XR patent settlements; Actavis outlines South America aims
6 October 2011
Indian pharma sales to reach $9.5B in 2010
29 October 2007
India's Intas spearheads EU entry via UK
30 May 2005
Showing 1-3 of 3 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
